Tenelitaq Duo Sustained-Release Tablet 10/750 mg

Adult dose

This medication is usually administered once daily with the evening meal. In order to reduce gastrointestinal side effects associated with Metformin, doses are adjusted gradually. The 20/1000 mg sustained-release tablet is to be taken once daily, one tablet at a time. For patients taking the 10/750 mg or 10/500 mg sustained-release tablet, the dose is twice daily, taking two tablets simultaneously. Teneligliptin 20 mg is taken once daily along with Metformin.

This medication is used for the treatment of diabetes and helps control blood sugar. However, this medication should not be used by patients with impaired kidney function, heart failure, or acute kidney disease. Additionally, if a contrast agent is to be used for radiological examinations, it is essential to stop taking this medication 48 hours before the test and to resume only after confirming normal kidney function post-examination. It is safer for women who are pregnant or may become pregnant to avoid this medication. This medication can increase the risk of hypoglycemia when used in combination with other diabetes treatments, so it is essential to be aware of the symptoms of hypoglycemia and how to respond to them. Patients with impaired liver function or severe lung disease should also exercise caution when taking this medication. This medication can rarely cause a severe side effect known as lactic acidosis; in such cases, medical consultation should be sought immediately. Symptoms of lactic acidosis may include muscle pain, weakness, difficulty breathing, and abdominal pain, so it is crucial to report these symptoms promptly. Regular monitoring of kidney function and blood tests should be performed while using this medication, and it is advisable to periodically check vitamin B12 levels. Patients scheduled for surgery should discontinue this medication 48 hours prior and only resume after confirming normal kidney function post-surgery. Alcohol consumption may increase the risk of lactic acidosis, so it is vital not to consume alcoholic beverages excessively while taking this medication. In case of sudden abdominal pain, vomiting, difficulty breathing, or the occurrence of skin blisters during treatment, contacting a physician immediately is necessary. Particularly in the elderly, kidney function may decline, so dose adjustment and regular monitoring are required. The safety and efficacy of this medication in children have not been established, hence it is not to be used. In cases of overdose, seek immediate hospital treatment, and if necessary, the medication may be removed via hemodialysis. This medication should be kept out of the reach of children and should not be transferred to other containers.

Serious side effects

Severe lactic acidosis, severe hypoglycemia, severe allergic reactions (including hives), severe edema, difficulty breathing, acute pancreatitis, liver dysfunction (including symptoms such as jaundice), interstitial pneumonia, blistering similar to bullous pemphigoid, acute renal failure, severe neurological symptoms (including cerebral infarction, hepatic coma, confusion, cerebral infarction), cardiovascular collapse (shock), acute myocardial infarction, sepsis, severe infections, and serious skin adverse reactions (severe rash,

Mild side effects

• Constipation
• dizziness
• abdominal bloating
• abdominal discomfort
• nausea
• abdominal pain
• flatulence
• stomatitis
• gastric polyp
• colon polyp

This medication should be stored in a tightly closed container to prevent air or moisture infiltration, ideally at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the drug's effectiveness for a longer duration.

Appearance

Yellow egg-shaped sustained-release film-coated tablets

Package unit

30 tablets/bottle